Tarsus Pharmaceuticals Inc.
TARS | NASDAQ
$77.46
-$0.63 (-0.81%)
At close: Sep 21, 2026, 4:00 PM ET
$77.46
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 173.91M | 162.05M | 151.67M | 118.7M | 102.66M | 78.34M | 66.41M | 48.12M | 40.81M | 27.61M | 13.08M | 1.87M | n/a | 2.5M | 10M | n/a | 15.28M | 539K | 338K | 1.24M | 22.02M | 33.43M |
Cost of Revenue | 12.11M | 9.4M | 10.93M | 24.59M | 6.24M | 5.21M | 4.93M | 3.24M | 3M | 1.65M | 1.22M | 377K | 316K | 255K | 400K | 211K | 522K | 33K | -24K | 65K | 737K | 1.3M |
Gross Profit | 161.8M | 152.66M | 140.74M | 94.1M | 96.42M | 73.12M | 61.48M | 44.88M | 37.81M | 25.96M | 11.86M | 1.49M | -316K | 2.25M | 9.6M | -211K | 14.76M | 506K | 362K | 1.18M | 21.28M | 32.13M |
Operating Income | -19.91M | -6.12M | -7.98M | -14.53M | -22.18M | -26.28M | -24.42M | -25.16M | -33.3M | -37.68M | -44.45M | -40.94M | -32.82M | -24.95M | -15.06M | -22.91M | -5.22M | -19.52M | -14.45M | -15.71M | 7.28M | 10.71M |
Interest Income | 3.7M | 3.72M | 3.95M | 4.11M | 4.23M | 3.45M | 3.65M | 4.12M | 4.13M | 3.12M | 2.98M | 2.84M | 2.23M | 2.29M | 2.13M | 1.06M | 297K | n/a | 12K | 8K | 7K | 9K |
Pretax Income | -15.84M | -9.32M | -6.31M | -12.59M | -20.34M | -25.12M | -23.11M | -23.42M | -33.29M | -35.73M | -41.9M | -39.15M | -31.42M | -23.42M | -13.6M | -22.52M | -5.74M | -20.24M | -14.8M | -16.04M | 6.37M | 10.69M |
Net Income | -18.55M | -6.97M | -8.37M | -12.59M | -20.34M | -25.12M | -23.11M | -23.42M | -33.29M | -35.73M | -41.9M | -39.15M | -31.42M | -23.42M | -13.6M | -22.51M | -5.74M | -20.24M | -14.85M | -15.7M | 6.3M | 10.29M |
Selling & General & Admin | 150.7M | 136.43M | 130.68M | 108.63M | 103.01M | 85M | 69.03M | 57.91M | 58.79M | 51.58M | 43.01M | 30.32M | 19.96M | 14.84M | 14.63M | 11.78M | 10.38M | 7.95M | 6.77M | 6.67M | 6.79M | 5.16M |
Research & Development | 31.01M | 22.35M | 18.04M | 16.28M | 15.59M | 14.41M | 16.87M | 12.13M | 12.32M | 12.07M | 13.31M | 12.11M | 12.55M | 12.36M | 10.03M | 10.91M | 9.6M | 12.08M | 8.04M | 10.21M | 7.2M | 16.26M |
Other Expenses | n/a | n/a | n/a | -16.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 181.71M | 158.78M | 148.72M | 108.63M | 118.61M | 99.4M | 85.9M | 70.04M | 71.11M | 63.64M | 56.31M | 42.43M | 32.51M | 27.2M | 24.66M | 22.7M | 19.98M | 20.03M | 14.81M | 16.88M | 14M | 21.42M |
Interest Expense | 2.16M | 2.13M | 2.21M | 2.12M | 2.09M | 2.07M | 2.17M | 2.32M | 2.11M | 983K | 989K | 858K | 815K | 684K | 692K | 633K | 544K | 316K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 193.82M | 168.18M | 159.64M | 133.23M | 124.84M | 104.62M | 90.83M | 73.28M | 74.12M | 65.3M | 57.53M | 42.81M | 32.82M | 27.45M | 25.06M | 22.91M | 20.5M | 20.06M | 14.79M | 16.95M | 14.74M | 22.72M |
Income Tax Expense | 2.72M | -2.35M | 2.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | n/a | 1K | 54K | -341K | 29K | 313K |
Shares Outstanding (Basic) | 43.39M | 42.96M | 42.78M | 42.61M | 42.36M | 39.35M | 38.56M | 38.38M | 37.82M | 35.3M | 31.94M | 30.62M | 26.82M | 26.74M | 25.68M | 26.66M | 24.33M | 20.71M | 20.63M | 20.64M | 20.56M | 20.34M |
Shares Outstanding (Diluted) | 43.39M | 42.96M | 42.78M | 42.61M | 42.36M | 39.35M | 38.56M | 38.38M | 37.82M | 35.3M | 31.94M | 30.62M | 26.82M | 26.74M | 25.68M | 26.66M | 24.33M | 20.71M | 20.63M | 20.64M | 21.97M | 21.82M |
EPS (Basic) | -0.43 | -0.16 | -0.20 | -0.30 | -0.48 | -0.64 | -0.60 | -0.61 | -0.88 | -1.01 | -1.31 | -1.28 | -1.17 | -0.88 | -0.53 | -0.84 | -0.24 | -0.98 | -0.72 | -0.76 | 0.31 | 0.51 |
EPS (Diluted) | -0.43 | -0.16 | -0.20 | -0.30 | -0.48 | -0.64 | -0.60 | -0.61 | -0.88 | -1.01 | -1.31 | -1.28 | -1.17 | -0.88 | -0.53 | -0.84 | -0.24 | -0.98 | -0.72 | -0.76 | 0.29 | 0.47 |
EBITDA | -12.68M | -6.75M | -3.66M | -12.13M | -17.65M | -22.45M | -20.37M | -20.68M | -30.94M | -34.48M | -40.57M | -38.08M | -30.43M | -22.66M | -12.81M | -21.84M | -5.11M | -19.88M | -14.76M | -15.96M | 6.54M | 10.8M |
EBIT | -13.68M | -7.19M | -4.1M | -12.59M | -18.1M | -22.91M | -20.8M | -20.98M | -31.18M | -34.75M | -40.91M | -38.32M | -30.61M | -22.76M | -12.91M | -21.93M | -5.2M | -19.92M | -14.8M | -16.04M | 6.37M | 10.69M |
Depreciation & Amortization | 1M | 437K | 443K | 460K | 453K | 460K | 432K | 300K | 239K | 270K | 347K | 244K | 182K | 104K | 98K | 94K | 92K | 41K | 40K | 83K | 169K | 107K |
Add to Watchlist
Select watchlists to add or remove TARS